TLRY stock

Tilray Inc (TLRY) earnings · rev $915.5M

These earnings events as JSON? API free 100/day

Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.

This TLRY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.

When the next TLRY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 11.5% from 2025-05-31 to 2026-05-31. An earnings headline that ignores that move is noise.

Not investment advice. Full TLRY research stays on the stock page; the tape stays on the quote page.

TLRY earnings FAQ

What are TLRY's latest revenue and net income?

Latest cached Tilray Inc (TLRY) revenue for May 31, 2026 was $915.5M. Net income was -$121.4M. Statements: https://lician.com/financials/tlry

What is TLRY's latest diluted EPS?

Latest cached Tilray Inc (TLRY) diluted EPS for May 31, 2026 was -$1.09.

What period does the latest TLRY earnings print cover?

The latest cached Tilray Inc (TLRY) earnings print covers May 31, 2026. The prior cached period on this page is May 31, 2025.

How did TLRY revenue change from the prior cached period?

Cached Tilray Inc (TLRY) revenue was up 11.5% from $821.3M (May 31, 2025) to $915.5M (May 31, 2026). Statements: https://lician.com/financials/tlry

Where are TLRY earnings listed?

Cached earnings facts for Tilray Inc (TLRY) are listed at https://lician.com/earnings/tlry. Statements: https://lician.com/financials/tlry

Not investment advice.

Full TLRY analysis